TORRENT PHARMACEUTICALS
Back to Balance Sheet
|
TORRENT PHARMACEUTICALS Last 5 Year Contingent Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹156 Cr | ₹157 Cr | ₹151 Cr | ₹129 Cr | ₹123 Cr |
What is the latest Contingent Liabilities ratio of TORRENT PHARMACEUTICALS ?
| Year | Contingent Liabilities |
|---|---|
| Mar2025 | ₹156 Cr |
| Mar2024 | ₹157 Cr |
| Mar2023 | ₹151 Cr |
| Mar2022 | ₹129 Cr |
| Mar2021 | ₹123 Cr |
How is Contingent Liabilities of TORRENT PHARMACEUTICALS Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹156 Cr | -0.84 | |
| Mar2024 | ₹157 Cr | 4.38 | |
| Mar2023 | ₹151 Cr | 17.16 | |
| Mar2022 | ₹129 Cr | 4.76 | |
| Mar2021 | ₹123 Cr | - | |
Compare Contingent Liabilities of peers of TORRENT PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| TORRENT PHARMACEUTICALS | ₹120,439.9 Cr | -1% | -1.2% | 8.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹405,452.0 Cr | -0.3% | 6% | -10.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹179,089.0 Cr | 3.9% | 18.6% | 14.5% | Stock Analytics | |
| CIPLA | ₹121,299.0 Cr | -5.2% | NA | 2.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹99,965.9 Cr | -6.8% | -2.1% | -8.4% | Stock Analytics | |
| MANKIND PHARMA | ₹98,333.5 Cr | -1.4% | -2.2% | 0.7% | Stock Analytics | |
TORRENT PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| TORRENT PHARMACEUTICALS | -1% |
-1.2% |
8.7% |
| SENSEX | -0.3% |
4.5% |
5.7% |
You may also like the below Video Courses